Resverlogix

202, 279 Midpark Way SE
Calgary, AB, CANADA, T2X 1M2
Phone:
(403) 254-9252
[email protected]
www.resverlogix.com
Product Categories:
Pharmaceuticals

Related Content

News | November 15, 2013
Drug Lowers Inflammation, MACE Events While Regressing Atheroma in High Risk CVD Patients
Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE ...
read more
News | September 28, 2011
Resverglogix Study Examines Atherosclerotic Plaque Regression Drug
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in...
read more
News | December 23, 2009
Cleveland Clinic Tests Drug to Increase HDL Production
December 23, 2009 – The Cleveland Clinic this week initiated a phase II trial examining a new oral therapy for the...
read more
News | October 02, 2009
Resverlogix RVX-208 Clinical Trial Demonstrates Key Reverse Cholesterol Transport Markers
October 2, 2009 – Resverlogix Corp. said this week results from the company's second clinical trial for the drug RVX-...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init